Celularity Inc. (CELUW) has a negative trailing P/E of -0.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 0.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -220.18%, forward earnings yield 10,000.00%.
Criteria proven by this page:
Overall SharesGrow Score: 38/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2018 | -320,753.6 | 0.00 | -2,798.54 | 20.06 | - |
| 2019 | -1.1 | 0.00 | 1.72 | 11.23 | - |
| 2020 | -1.0 | -0.04 | 10.83 | 14.19 | - |
| 2021 | -3.4 | 0.04 | 3.45 | 16.09 | - |
| 2022 | 12.7 | -0.12 | 0.91 | 10.04 | - |
| 2023 | -0.2 | 0.00 | 1.07 | 1.93 | - |
| 2024 | -0.8 | 0.01 | 5.15 | 0.84 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2018 | $0.00 | $17.55M | $-1.1K | -0% |
| 2019 | $2.46 | $21.15M | $5.88M | 27.8% |
| 2020 | $-17.00 | $14.28M | $-208.23M | -1458.4% |
| 2021 | $-14.90 | $21.34M | $-100.12M | -469.3% |
| 2022 | $0.95 | $17.98M | $14.19M | 79% |
| 2023 | $-11.02 | $22.77M | $-196.3M | -862% |
| 2024 | $-2.64 | $54.22M | $-57.89M | -106.8% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-2.75 | $-2.75 – $-2.75 | $44M | $44M – $44M | 1 |
| 2027 | $1.50 | $1.50 – $1.50 | $285.66M | $285.66M – $285.66M | 1 |
